Psomagen, Inc. (KOSDAQ: 950200)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,060.00
+15.00 (0.37%)
Jan 22, 2025, 3:00 PM KST
-24.11%
Market Cap 78.10B
Revenue (ttm) 38.14B
Net Income (ttm) -6.04B
Shares Out 19.24M
EPS (ttm) -345.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,996
Average Volume 20,757
Open 4,050.00
Previous Close 4,045.00
Day's Range 4,025.00 - 4,065.00
52-Week Range 3,765.00 - 6,700.00
Beta 0.10
RSI 42.91
Earnings Date Mar 21, 2025

About Psomagen

Psomagen, Inc. engages in the provision omics solutions and contract laboratory services. The company’s research services comprises of genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; single-cell analysis, research in suspensions, biological fluids, tissues, or cell populations; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its express... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Employees 89
Stock Exchange KOSDAQ
Ticker Symbol 950200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.